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Abstract
Here we outline a next-generation RNA sequencing protocol that enables de novo assemblies and intra-host variant calls of viral genomes
collected from clinical and biological sources. The method is unbiased and universal; it uses random primers for cDNA synthesis and requires
no prior knowledge of the viral sequence content. Before library construction, selective RNase H-based digestion is used to deplete unwanted
RNA — including poly(rA) carrier and ribosomal RNA — from the viral RNA sample. Selective depletion improves both the data quality and
the number of unique reads in viral RNA sequencing libraries. Moreover, a transposase-based 'tagmentation' step is used in the protocol as it
reduces overall library construction time. The protocol has enabled rapid deep sequencing of over 600 Lassa and Ebola virus samples-including
collections from both blood and tissue isolates-and is broadly applicable to other microbial genomics studies.
Video Link
The video component of this article can be found at http://www.jove.com/video/54117/
Introduction
Next generation sequencing of viruses from clinical sources can inform transmission and the epidemiology of infections, as well as help support
novel diagnostic, vaccine and therapeutic development. cDNA synthesis using random primers has allowed the detection and assembly
of genomes from divergent, co-infecting or even novel viruses1,2. As with other unbiased methods, unwanted contaminants occupy many
sequencing reads and negatively impact sequencing results. Host and poly(rA) carrier RNA are contaminants present in many existing viral
sample collections.
The protocol describes an efficient and cost-effective way of deep sequencing RNA virus genomes based on unbiased total RNA-seq. The
method utilizes an RNase H selective depletion step3 to remove unwanted host ribosomal and carrier RNA. Selective depletion enriches for viral
content (Figure 1) and improves the overall quality of sequencing data (Figure 2) from clinical samples. Moreover, tagmentation is applied to
the protocol as it significantly reduces library construction time. These methods have been used to rapidly generate large datasets of Ebola and
Lassa virus genomes2,4,5 and can be used to study a wide range of RNA viruses. Lastly, the approach is not limited to human samples; the utility
of selective depletion was demonstrated on tissue samples collected from Lassa-infected rodents and non-human primate disease models5,6.
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Figure 1. Total RNA Content Reflects Enrichment of Lassa Virus Content Using Selective Depletion. Starting overall content (RNA input)
and enrichment of unique Lassa virus (LASV) reads (Library content) upon rRNA depletion from nine different clinical isolates. This figure has
been modified from6. Please click here to view a larger version of this figure.
 
Figure 2. Higher Quality Sequencing After Carrier RNA Depletion. Median base qualities per sequencing cycle of poly(rA)-contaminated
Lassa virus libraries (red) and control (no carrier observed in library, black) from QC report 13. Both read 1 and read 2 of paired end reads are
merged in the library BAM file and the quality scores are shown at each base. This figure has been modified from6. Please click here to view a
larger version of this figure.
The viral RNA-seq protocol details construction of libraries directly from extracted RNA collected from clinical and biological samples. To
ensure personal safety, all viral serum, plasma and tissue samples should be inactivated in appropriate buffers prior to RNA extraction. In some
inactivation and extraction kits, carrier poly(rA) RNA is included; this will be removed during the initial RNase H selective depletion step. Based
on complete recovery, the expected concentration of carrier RNA is 100 ng/µl. In the protocol, 110 ng/µl oligo dT RNA (1.1x carrier concentration)
is used for depletion. If poly(rA) carrier is not present in the sample, then oligo(dT) should not be added prior to depletion.
The following protocol is designed for 24 reactions in PCR plate format (up to 250 µl volume). An earlier version of this protocol was reported in
Matranga, et al.6.
Protocol
Ethics statement: Lassa fever patients were recruited for this study using protocols approved by human subjects committees at Tulane
University, Harvard University, Broad Institute, Irrua Specialist Teaching Hospital (ISTH), Kenema Government Hospital (KGH), Oyo State
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Ministry of Health, Ibadan, Nigeria and Sierra Leone Ministry of Health. All patients were treated with a similar standard of care and were offered
the drug Ribavirin, whether or not they decided to participate in the study. For Lassa fever (LF) patients, treatment with Ribavirin followed the
currently recommended guidelines and was generally offered as soon as LF was strongly suspected.
Due to the severe outbreak for Ebola Virus Disease (EVD), patients could not be consented through our standard protocols. Instead use
of clinical excess samples from EVD patients was evaluated and approved by Institutional Review Boards in Sierra Leone and at Harvard
University. The Office of the Sierra Leone Ethics and Scientific Review Committee, the Sierra Leone Ministry of Health and Sanitation, and the
Harvard Committee on the Use of Human Subjects have granted a waiver of consent to sequence and make publically available viral sequences
obtained from patient and contact samples collected during the Ebola outbreak in Sierra Leone. These bodies also granted use of clinical and
epidemiological data for de-identified samples collected from all suspected EVD patients receiving care during the outbreak response. The Sierra
Leone Ministry of Health and Sanitation also approved shipments of non-infectious, non-biological samples from Sierra Leone to the Broad
Institute and Harvard University for genomic studies of outbreak samples.
1. DNase-treatment of Sample RNA (Up to 55 µl Extracted Total RNA, ~4 hr)
1. Set up the DNase reaction in a 96-well PCR plate on ice in a biosafety cabinet as described in Table 1, Step 1.1 (total volume, 70 µl/well).
Note: A master mix can be prepared.
2. Vortex gently and thoroughly, then centrifuge at 280 x g at RT for 1 min.
3. Incubate at 37 °C for 30 min.
4. Cleanup using RNA Solid Phase Reversible Immobilization (SPRI) beads.
1. Warm RNA beads to RT for 30 min.
2. Gently shake RNA beads bottle to resuspend any magnetic particles that may have settled. Add 1.8x volume (126 µl) of RNA beads to
DNase-treated RNA (70 µl), mix by pipette 10 times and incubate for 5 min at RT (total volume in well, 196 µl).
3. Place mixture on the magnetic station. Wait for the solution to clear (5 - 10 min).
4. Remove cleared solution while on the station by pipette and discard. While on station, wash beads by covering pellet with 70% ethanol
and incubate for 1 min. Remove ethanol with pipette and discard. Repeat for a total of two washes.
 
Note: Using precisely 70% freshly prepared ethanol is critical, as a higher percentage will result in inefficient washing of smaller-sized
molecules, whereas <70% ethanol could cause loss of sample7.
5. Keep plate on the station and leave open to air-dry. Note: Be sure to allow the beads to dry completely until beads begin to crack.
6. Add 55 µl of nuclease-free water to the plate to elute RNA. Remove plate from the station to mix the beads and water by pipetting
thoroughly. Note: Alternatively, use less water (≤ 10 µl) in order to concentrate the total RNA.
7. Place plate back on the station. Wait until solution clears to transfer by pipette to new screw-cap tube for long-term storage (-80 °C).
Place 5 µl RNA in new 96-well PCR plate for depletion (step. 2.4).
8. Optional: Save and dilute 1 µl in 19 µl water (1:20) for qRT-PCR of rRNA (e.g., 18S, 28S rRNA) (Table 2) and viral markers5.
2. Selective Depletion of Ribosomal and Carrier RNA from Viral RNA Sample (~4 hr)
1. Make 5x hybridization and 10x RNase H reaction buffers, and nuclease-free water with linear acrylamide carrier as described in Table 1.
2. Set up hybridization reaction by combining RNA with rRNA depletion oligos (Table 3) and oligo(dT) on ice in a 96-well PCR plate as
described in Table 1.
 
Note: A master mix can be prepared. 50 femtograms (fg) of a unique synthetic RNA (ERCCs8) can be added for tracking both the viral
sequencing process and potential index read cross-contamination.
1. Vortex gently and thoroughly, then centrifuge at 280 x g at RT for 1 min.
 
Incubate at 95 °C for 2 min, slow ramping to 45 °C at -0.1 °C per sec. Pause the thermocycler at 45 °C.
3. Set up RNase H reaction mix on ice as described in Table 1, then preheat at 45 °C for 2 min. Note: A master mix can be prepared.
1. Add the pre-heated RNase H mix to the hybridization reaction in plate while keeping the plate in the thermocycler at 45 °C.
2. Mix well by gentle pipetting 6 - 8 times. Incubate at 45 °C for another 30 min. Place on ice.
4. Set up the DNase reaction mix on ice as described in Table 1. Note: A master mix can be prepared.
1. Add to the RNase H reaction in plate, vortex gently and thoroughly, then centrifuge at 280 x g at RT for 1 min. Incubate at 37 °C for 30
min.
2. Stop DNase reaction by adding 5 µl 0.5 M EDTA. Vortex gently and thoroughly, then centrifuge at 280 x g at RT for 1 min.
5. Cleanup using RNA beads (see step 1.3) using a 1.8x volume (144 µl) beads. Elute in 11 µl of nuclease-free water. Note: For safe cold
storage, store depleted RNA samples at -80 °C O/N.
3. cDNA Synthesis (~6 hr)
1. Mix rRNA/carrier-depleted RNA with random primers on ice in a 96-well PCR plate as described in Table 1, vortex gently and thoroughly, then
centrifuge at 280 x g at RT for 1 min.
1. Heat the mixture to 70 °C for 10 min in a thermocycler. Immediately after heat denaturation, place the RNA on ice for 1 - 5 min. Do not
allow the RNA to stand (even on ice) for longer than 5 min prior to the first-strand reaction.
2. Set up first-strand synthesis reaction mix on ice as described in Table 1.
 
Note: A master-mix may be prepared.
1. Add to RNA/random primer mix in plate, vortex gently and thoroughly, then centrifuge at 280 x g at RT for 1 min. Incubate at 22 - 25 °C
for 10 min.
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2. Incubate at 55 °C in an air incubator for 60 min. Place the plate on ice to terminate the reaction. Note: The use of an air incubator is
recommended to create gradual warming of the first-strand reaction during which the primers anneal and the first strand begins to
elongate.
3. Set up second-strand synthesis reaction mix on ice as described in Table 1.
 
Note: A master-mix may be prepared.
1. Add to the first-strand synthesis reaction in the plate, vortex gently and thoroughly, then centrifuge at 280 x g at RT for 1 min. Incubate
for 2 hr at 16 °C (keep lid at 25 °C). Do not allow the temperature to rise above 16 °C.
2. Place the plate on ice, then inactivate reaction by adding 5 µl of 0.5 M EDTA, mix gently and thoroughly, then centrifuge at 280 x g at
RT for 1 min.
4. Cleanup with DNA beads (see step 1.3 for protocol) using 1.8x volume (153 µl) of beads. Elute in 9 µl of elution buffer (EB). Save 1 µl for
quantification. Use 1 ng of cDNA for subsequent steps. If cDNA concentration is too low to detect, use 4 µl of cDNA for tagmentation (see
step 4.1).
5. For safe cold storage, store double-stranded cDNA at 4 °C O/N or -20 °C for long-term storage.
4. Library Preparation — DNA Library Construction (~4 hr)
1. Transfer 4 µl of cDNA to a 96-well plate and save the remaining cDNA for a second attempt if needed.
2. Set up the tagmentation reaction on ice as described in Table 1.
 
Note: A master-mix may be prepared. To reduce background and overall cost, the total volume of the tagmentation reaction is reduced from
20 to 10 µl. As cDNA is the limiting factor, the amount of ATM (i.e., transposome) used in the reaction is also reduced to decrease the number
of integration sites.
1. Add tagmentation mix to cDNA in the plate, vortex gently and thoroughly and centrifuge at 280 x g (at RT) for 1 min. Incubate at 55 °C
for 5 min, hold at 10 °C.
2. Once at 10 °C, immediately add 2.5 µl of Neutralize Tagment Buffer (NT) to end the reaction. Mix by pipetting up and down, then
centrifuge at 280 x g (at RT) for 1 min.
3. Incubate at RT for 5 min.
3. Set up PCR amplification reaction on ice as described in Table 1.
1. Vortex gently and thoroughly, then centrifuge at 280 x g at RT for 1 min.
2. Perform PCR on thermocycler using the conditions described in Table 1.
 
Note: 12 cycles of PCR are suggested for 1 ng of tagmented cDNA; however, viral clinical samples often have undetectable amounts of
cDNA. For low amounts of cDNA (<1 ng), use up to 18 cycles of PCR to create enough library for sequencing.
4. Library preparation — cleanup and pooling for sequencing
1. Bring sample up to 50 µl with EB.
2. Cleanup with DNA beads (see step 1.3 for protocol) using 0.6x volume (30 µl) beads. Elute in 15 µl EB.
3. Determine concentration of library (Figure 3) by conducting region analysis (150 to 1,000 bp) using bioanalyzer software9, excluding
primer dimers (~120 bp) from region analysis. Note: Alternatively, qPCR can be used to quantify libraries 10.
4. Pool libraries at the lowest molar concentration of 1 nM or greater. If library is below 1 nM, add a small volume of library to pool (~1x
volume of other libraries) to capture sequence information from these libraries.
5. Cleanup pool with 0.7x DNA beads as outlined above (see step 2). Elute in 15 µl EB. Note: Volume of beads will depend on the final
volume of the pool.
6. Analyze pool9. Determine molar concentration by conducting region analysis (150 to 1,000 bp)9. Note: Alternatively, qPCR can be used
to quantify library pool 10.
7. Load sequencer at 10 pM library concentration to generate 101 bp, paired-end reads with dual barcode reads11.
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Figure 3. Libraries Constructed from Ebola Virus Clinical Samples. Gel image of 4 representative Ebola virus (EBOV) libraries. Regions of
library and primer dimers are shown. Please click here to view a larger version of this figure.
Representative Results
The described protocol enables the generation of high quality sequencing reads from low-input viral RNA samples while enriching for unique
viral content. As shown in Figure 1, the protocol enriched unique Lassa virus content at least five-fold in all samples (compared to non-depleted
controls) with at least one million copies of 18S rRNA (~100 pg total RNA). Likewise, sequencing success also correlated with the amount of
virus within a given sample. Using qRT-PCR as a surrogate for viral quantity, samples that contained ~1,000 or more viral genome copies most
often created full assemblies (data not shown). Moreover, depletion of poly(rA) carrier reduces homopolymer sequences of A and T in libraries,
resulting in cleaner preparations and ensuring better quality sequencing reads (Figure 2). Final libraries from low input viral clinical samples
often have a broad fragment length from 150 to 1,000 bp (Figure 3).
After sequencing, to reduce sample misidentification and crosstalk between libraries within a pool12, only index reads with a base quality score of
25 (q25) and ensure zero mismatches are kept during the demultiplexing process. Viral genomes are assembled using a bioinformatics pipeline
specific for divergent viruses2,4-6. These tools are available at https://github.com/broadinstitute/viral-ngs or through commercial cloud platforms4.
Step 1.1: DNase reaction
Reagent Volume per reaction (µl)
10x DNase buffer 7
Nuclease-free water 6
Extracted viral RNA 55
DNase (2 U/µl) 2
Total volume 70
Step 2.1: 5x Hybridization buffer
Reagent Volume for 1 ml (µl)
5 M NaCl 200
1 M Tris-HCl (pH 7.4) 500
Nuclease-free water 300
Total volume 1,000
Step 2.1: 10x RNase H reaction buffer
Reagent Volume for 1 ml (µl)
5 M NaCl 200
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1 M Tris-HCl (pH 7.5) 500
1 M MgCl2 200
Nuclease-free water 500
Total volume 1,000
Step 2.1: Water with linear acrylamide
Reagent Volume for 1 ml buffer (µl)
Nuclease-free water 992
Linear acrylamide (5 mg/ml) 8
Total volume 1,000
Step 2.2: Hybridization reaction for selective depletion
Reagent Volume per reaction (µl)
5x Hybridization Buffer 2
rRNA-depletion oligo mix (100 µM) 1.22
Oligo(d)T (550 ng/µl) 1
DNase-treated total RNA up to 5
Spike-in RNA (This is optional) 0.5
Water (with linear acrylamide) bring up to 10 total
Total volume 10
Step 2.3: RNase H reaction for selective depletion
Reagent Volume per reaction (µl)
10x RNase H Reaction Buffer       2
Water (with linear acrylamide) 5
Thermostable RNase H (5 U/µl) 3
Total volume 10
Step 2.4: DNase reaction post selective depletion
Reagent Volume per reaction (µl)
10x DNase Buffer 7.5
Water (with linear acrylamide) 44.5
RNase inhibitor (20 U/µl) 1
RNase-free DNase I (2.72 U/µl) 2
Total volume (with RNase H reaction) 75
Step 3.1:  cDNA synthesis, random primer hybridization
Reagent Volume per reaction (µl)
rRNA/carrier-depleted RNA 10
3 µg random primer 1
Total volume 11
Step 3.2: First strand cDNA synthesis reaction
Reagent Volume (µl)
5x First-Strand Reaction Buffer 4
0.1 M DTT 2
10 mM dNTP mix 1
RNase inhibitor (20 U/µl) 1
Reverse transcriptase (add last) 1
Total volume (with RNA above) 20
Step 3.3: Second strand cDNA synthesis reaction
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Reagent Volume (µl)
RNase-free water 43
10x Second-Strand Reaction Buffer 8
10 mM dNTP mix 3
E. coli DNA Ligase (10 U/µl) 1
E. coli DNA Polymerase I (10 U/µl) 4
E. coli RNase H (2 U/µl) 1
Total volume (with 1st strand reaction) 80
Step 4.2:  Tagmentation reaction
Reagent Volume (µl)
Amplicon Tagment Mix (ATM) 1
Tagment DNA Buffer (TD) 5
Total volume (with cDNA) 10
Step 4.3: Library PCR reaction
Reagent Volume (µl)
PCR Master Mix (NPM) 7.5
Index 1 primer (i7) 2.5
Index 2 primer (i5) 2.5
Total volume (with tagmented cDNA) 25
Step 4.3.2: Library PCR conditions
72 °C, 3 min
95 °C, 30 sec
up to 18 cycles-10 sec at 95 °C, 30 sec at 55 °C, 30 sec at 72 °C
72 °C, 5 min
10 °C, forever
Table 1: Reaction set-up and buffers. Step-by-step tables with contents of all buffers and reaction mixes.
Oligo Name Sequence (5' to 3')
Ebola KGH FW GTCGTTCCAACAATCGAGCG
Ebola KGH RV CGTCCCGTAGCTTTRGCCAT
Ebola KULESH FW TCTGACATGGATTACCACAAGATC
Ebola KULESH RV GGATGACTCTTTGCCGAACAATC
Lassa SL FW GTA AGC CCA GCD GYA AAB CC
Lassa SL RV AAG CCA CAG AAA RCT GGS AGC A
18S rRNA FW TCCTTTAACGAGGATCCATTGG
18S rRNA RV CGAGCTTTTTAACTGCAGCAACT
Table 2: qRT-PCR Primers Sequences. Primers used for measuring host (18S rRNA) and viral (Ebola and Lassa) content. 'KGH' is Kenema
Government Hospital in Sierra Leone, where the Ebola primers were tested 2. 'Kulesh' is the investigator who designed the primer set 14.
Table 3: Ribosomal RNA (rRNA) Depletion Oligos. 195 50-nucleotide long sequences complementary to human rRNA for selective depletion
step6. Please click here to download this file.
Discussion
The outlined approach enables robust, universal, rapid sequencing and was used for sequencing Ebola virus during the 2014 outbreak2,4. By
coupling selective depletion and cDNA synthesis with tagmentation library construction, the overall process time was reduced by ~2 days from
previous adapter ligation methods. More recently, this protocol was employed by international collaborators and others with great success15,16
and will be deployed to labs in West Africa to support local genomics-based research studies and diagnostics17.
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The protocol described here uses random primers to prepare cDNA for viral RNA-seq libraries. Unlike previous viral RNA-seq approaches, it
requires no a priori knowledge of sequence data or elaborate and time-consuming primer design for a specific virus or clade. The method can be
applied to any viral RNA sample. For example, it was used to generate viral content from both Ebola and Lassa samples6. The protocol may also
be used for host transcriptomic, metagenomic and pathogen discovery sequencing projects 1.
A critical step of the protocol is targeted RNase H digestion, a high-throughput, low cost method for removing unwanted carrier and host RNA
from viral samples. The selective depletion step of the protocol uses many components and requires skill and accuracy. Extra time and care
should be taken during the initial setup.
As most clinical serum and plasma samples often have very little nucleic acid material, contamination and sample loss are common. To avoid
these issues, special care should be taken when using this protocol. First, RNA is highly susceptible to degradation; therefore all areas should be
clean and free of nucleases. Second, to identify samples suitable for use in this protocol, qRT-PCR assays for both host RNA and virus should
be used for quantification5,6. When comparing input amounts with sequencing results from the protocol, sequencing success (i.e., generation of
sufficient data for full viral assembly) correlated with samples that contained at least 100 pg total RNA and 1,000 copies of virus. Third, exposure
to environmental sources of nucleic acids should be avoided. The protocol outlined here is done in a biosafety cabinet for safety precautions
and for limiting environmental contaminants. Moreover, our group and others have noticed that commercial enzymes may be another source
of contaminating bacterial nucleic acids in low input samples6,18. Use of a clean workspace (e.g., PCR hood, biosafety cabinet) and negative
controls (e.g., water or buffer) will help alleviate and track contamination, respectively. For samples with <100 pg of total RNA, only poly(rA)
carrier RNA, not rRNA, should be depleted to ensure high quality sequencing results while limiting loss of material. For very low input samples,
cDNA-amplification methods may be more suitable19, although poly(rA) carrier should be removed prior to the cDNA synthesis.
The depletion of host rRNA enriches for viral content in sequencing libraries and is applicable to different sample collections including serum or
plasma, and multiple types of tissues from rodents and non-human primates5,6. In non-human organisms, reads aligning to 28S rRNA remained
after depletion, suggesting 28S rRNA is less conserved between humans and other species6,20. When using this method with non-human
isolates, it may be necessary to supplement with DNA oligos complementary to the divergent rRNA sequences of the specific host 3,21.
Since the protocol is unbiased, viral reads may represent only a small fraction of total library content. Although rRNA is the most abundant
species of host RNA and only a small percentage of rRNA reads (<1%) are found after selective depletion, all other host RNA (e.g., mRNA)
will remain after depletion and may account for many sequencing reads from the sample. Therefore "oversampling" (i.e., oversequencing)
individual libraries is required in order to have enough coverage for viral assembly and variant calls. For our studies, we attempt to sequence
~20 million reads per sample to have enough depth for analysis of viral genomic and associated variants as well as metagenomic content2,5. For
metagenomic and pathogen discovery studies, it is important to note that contaminating host DNA is removed by DNase digestion. Therefore
viruses and other pathogens that contain DNA genomes may be lost during the process, however RNA intermediates may still be sequenced.
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